Live from the NIH registry
Studies recruiting near Nampa right now
Top 25 of 267 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
St. Alphonsus Regional Medical Center — Boise, Idaho (18.1 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Boise Kidney — Boise, Idaho (18.1 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: NRG Oncology
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Boise, Idaho (18.1 mi)
· Sponsor: Sameek Roychowdhury
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Boise, Idaho Investigative Site 10073 — Boise, Idaho (18.1 mi)
· Sponsor: Colorado Prevention Center
HBOT Effects on First Responders' Cognition and Well-Being
Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder
Phase 2
Interventional 54 participants sought
Summit Hyperbarics and Wellness — Boise, Idaho (18.1 mi)
· Sponsor: Summit Hyperbarics and Wellness
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Asr, Llc — Boise, Idaho (18.1 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Saint Luke's Cancer Institute - Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: NRG Oncology
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
Reducing Crises and Suicide Within the Idaho Army National Guard
Crisis Response Plan, Crisis Intervention
N/A
Interventional 450 participants sought
Idaho Army National Guard — Boise, Idaho (18.1 mi)
· Sponsor: University of Rochester
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
St Lukes Mountain States Tumor Institute — Boise, Idaho (18.1 mi)
· Sponsor: Gilead Sciences
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 3
Interventional 250 participants sought
Boise VA Medical Center — Boise, Idaho (18.1 mi)
· Sponsor: Ferring Pharmaceuticals
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research - Boise — Meridian, Idaho (8.8 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
HPV, HPV - Anogenital Human Papilloma Virus Infection
N/A
Interventional 260 participants sought
ASR Idaho CGI — Boise, Idaho (18.1 mi)
· Sponsor: Mel Mont Medical
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Growth Hormone Deficiency
N/A
Observational 900 participants sought
Ascendis Investigational Site — Boise, Idaho (18.1 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
St. Luke's Idaho Cardiology Associates — Meridian, Idaho (8.8 mi)
· Sponsor: Novo Nordisk A/S
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Saint Alphonsus Regional Medical Center ( Site 0067) — Boise, Idaho (18.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Phase 3
Interventional 333 participants sought
Consultants in Epilepsy & Neurology, PLLC — Boise, Idaho (18.1 mi)
· Sponsor: Rapport Therapeutics Inc.